EVENITY® is a bone forming agent with a dual effect1-4

EVENITY is a monoclonal antibody that binds and inhibits sclerostin,
exerting a dual effect on bone1-4

image

See how the dual effect of EVENITY improves fracture risk reduction and results in significant gains in BMD against alendronate4,5

Contact a member of our team to discover more
Learn about the efficacy of EVENITY
How EVENITY works

EVENITY has a dual effect on bone through activation, stimulation and formation of osteoblasts and indirect inhibition of osteoclasts through its effect on osteoclast-regulating factors.3

Learn more about the mechanism of action of EVENITY in this mode of action video.

View References
  1. Rosen CJ. N Engl J Med 2017;377:1479-1480.
  2. Cosman F, et al. N Engl J Med 2016;375:1532-1543.
  3. Ferrari SL. Nat Rev Rheumatol 2018;14:128.
  4. EVENITY SmPC.
  5. Saag KG, et al. N Engl J Med 2017;377:1417-1427.